Sánchez-Calderón, DianaPedraza A, Mancera Urrego CMejía-Mejía, AurelioMontealegre Paez, Ana LorenaPerdomo Lara, Sandra Janneth2020-03-062020-03-0620201178-6981https://hdl.handle.net/20.500.12495/2002application/pdfengAttribution-NonCommercial 4.0 InternationalAnalysis of the cost-effectiveness of liquid biopsy to determine treatment change in patients with her2-positive advanced breast cancer in ColombiaarticleNeoplasias de la mamaResistencia a antineoplásicosCostos de los medicamentosCost-effectivenessLiquid biopsyBiomarkershttps://doi.org/10.2147/CEOR.S220726instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coAnalysis of the cost-effectiveness of liquid biopsy to determine treatment change in patients with her2-positive advanced breast cancer in ColombiaAcceso abiertoinfo:eu-repo/semantics/openAccesshttps://purl.org/coar/access_right/c_abf3092020